RTSL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RTSL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Rapid Therapeutic Science Laboratories's EPS without NRI for the three months ended in Jun. 2023 was $-0.01.
During the past 3 years, the average EPS without NRI Growth Rate was 61.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 10 years, the highest 3-Year average EPS without NRI Growth Rate of Rapid Therapeutic Science Laboratories was 61.80% per year. The lowest was -303.30% per year. And the median was -60.20% per year.
For the Medical Devices subindustry, Rapid Therapeutic Science Laboratories's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Rapid Therapeutic Science Laboratories's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Rapid Therapeutic Science Laboratories's 3-Year EPS without NRI Growth Rate falls into.
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
Rapid Therapeutic Science Laboratories (OTCPK:RTSL) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Thank you for viewing the detailed overview of Rapid Therapeutic Science Laboratories's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Henry Anthony Punzi | director | 1932 WALNUT PLAZA, CARROLLTON TX 75006 |
Scott Suggs Justin | director | 639 SWORD BRIDGE DR., LEWISVILLE TX 75056 |
Sean Paul Berrier | 10 percent owner | 7108 DUFFIELD DR., DALLAS TX 75248 |
Schmidt Donal Ray Jr. | director, 10 percent owner, officer: President and CEO | 5580 PETERSON LANE, SUITE 200, DALLAS TX 75240 |
Ryan Casey Johnson | director, officer: Chief Operating Officer | 2307 CASTLE ROCK RD, CARROLTON TX 75007 |
Texas Mdi, Inc. | 10 percent owner | 5580 PETERSON LANE, SUITE 200, DALLAS TX 75240 |
D Hughes Watler | director, officer: CFO | 2323 S. VOSS ROAD, STE. 510-12, HOUSTON TX 77057 |
Steve Bond | director, officer: CFO | 28839 PUJOL ST., #832, TEMECULA CA 92590 |
Brent Willson | director, officer: CEO and President | 5271 CAMINITO EXQUISITO, SAN DIEGO CA 92130 |
From GuruFocus
By Marketwired Marketwired • 06-10-2021
By sperokesalga sperokesalga • 03-21-2023
By Marketwired Marketwired • 10-26-2021
By Don Li2 Don Li2 • 11-02-2021
By Don Li2 Don Li2 • 11-12-2021
By Value_Insider Value_Insider • 12-13-2022
By Marketwired Marketwired • 10-06-2021
By Marketwired Marketwired • 10-06-2021
By Marketwired Marketwired • 08-06-2020
By Marketwired Marketwired • 12-03-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.